caa a22 4500 469026448 CHVBK 20180323132731.0 cr unu---uuuuu 170328e19920801xx s 000 0 eng 10.1007/BF01962550 doi (NATIONALLICENCE)springer-10.1007/BF01962550 Harting J. Oosterschelde Hospital Foundation, Goes, the Netherlands aut New developments in the pharmacotherapy of inflammatory bowel disease [Elektronische Daten] [J. Harting] In this article the clinical features and aetiology of inflammatory bowel diseases are described and current pharmacotherapeutic possibilities are explored. Also reviewed are recent developments and future prospects for the pharmacotherapy of inflammatory bowel diseases, including aminosalicylates, corticosteroids, immunosuppressants, lipoxygenase inhibitors, fish oil, sucralfate, bismuth compounds, free radical scavengers, (hydroxy)chloroquine, sodium cromoglycate and methotrexate. Royal Dutch Association for Advancement of Pharmacy, 1992 Crohn's disease nationallicence Inflammatory bowel disease nationallicence Ulcerative colitis nationallicence Pharmaceutisch Weekblad Kluwer Academic Publishers 14/4(1992-08-01), 275-286 0031-6911 14:4<275 1992 14 11096 https://doi.org/10.1007/BF01962550 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01962550 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Harting J. Oosterschelde Hospital Foundation, Goes, the Netherlands aut NATIONALLICENCE 773 0- Pharmaceutisch Weekblad Kluwer Academic Publishers 14/4(1992-08-01), 275-286 0031-6911 14:4<275 1992 14 11096 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer